Process View
The network for 'mammary gland morphogenesis' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
The process in which anatomical structures of the mammary gland are generated and organized. Morphogenesis refers to the creation of shape. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Fgfr2 | fibroblast growth factor receptor 2 | 1.000 | |
Tbx1 | T-box 1 | 0.999 | |
Shh | sonic hedgehog | 0.995 | |
Bmp4 | bone morphogenetic protein 4 | 0.993 | |
Chrd | chordin | 0.992 | |
Apc | adenomatosis polyposis coli | 0.991 | |
Gli2 | GLI-Kruppel family member GLI2 | 0.990 | |
Fgfr1 | fibroblast growth factor receptor 1 | 0.985 | |
Nkx2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.983 | |
Sox9 | SRY-box containing gene 9 | 0.983 | |
Tbx3 | T-box 3 | 0.981 | |
Nodal | nodal | 0.979 | |
Fgf10 | fibroblast growth factor 10 | 0.973 | |
Pax2 | paired box gene 2 | 0.969 | |
Pax3 | paired box gene 3 | 0.968 | |
Fgfr3 | fibroblast growth factor receptor 3 | 0.968 | |
Bcl2 | B-cell leukemia/lymphoma 2 | 0.967 | |
Prrx2 | paired related homeobox 2 | 0.966 | |
Trp53 | transformation related protein 53 | 0.965 | |
Smad3 | MAD homolog 3 (Drosophila) | 0.959 | |
Foxc1 | forkhead box C1 | 0.957 | |
Tgfbr2 | transforming growth factor, beta receptor II | 0.957 | |
Smad4 | MAD homolog 4 (Drosophila) | 0.941 | |
Rara | retinoic acid receptor, alpha | 0.927 | |
Pitx2 | paired-like homeodomain transcription factor 2 | 0.919 | |
Rxra | retinoid X receptor alpha | 0.917 | |
Ctnnb1 | catenin (cadherin associated protein), beta 1 | 0.916 | |
Prrx1 | paired related homeobox 1 | 0.913 | |
Pitx1 | paired-like homeodomain transcription factor 1 | 0.911 | |
Pax8 | paired box gene 8 | 0.911 | |
Rarg | retinoic acid receptor, gamma | 0.895 | |
Robo1 | roundabout homolog 1 (Drosophila) | 0.891 | |
Pten | phosphatase and tensin homolog | 0.889 | |
Pdgfra | platelet derived growth factor receptor, alpha polypeptide | 0.880 | |
Fgf8 | fibroblast growth factor 8 | 0.874 | |
Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.860 | |
Zeb1 | zinc finger E-box binding homeobox 1 | 0.852 | |
Six1 | sine oculis-related homeobox 1 homolog (Drosophila) | 0.831 | |
Dlx5 | distal-less homeobox 5 | 0.814 | |
Bmp7 | bone morphogenetic protein 7 | 0.806 | |
Foxn1 | forkhead box N1 | 0.802 | |
Hand2 | heart and neural crest derivatives expressed transcript 2 | 0.753 | |
Hoxa1 | homeobox A1 | 0.748 | |
Slit2 | slit homolog 2 (Drosophila) | 0.740 | |
Acvr1 | activin A receptor, type 1 | 0.739 | |
Efnb2 | ephrin B2 | 0.738 | |
Erbb2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.732 | |
Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 0.732 | |
Otx2 | orthodenticle homolog 2 (Drosophila) | 0.725 | |
Csf1 | colony stimulating factor 1 (macrophage) | 0.722 | |
Lepr | leptin receptor | 0.716 | |
Foxc2 | forkhead box C2 | 0.705 | |
Hand1 | heart and neural crest derivatives expressed transcript 1 | 0.699 | |
Gli3 | GLI-Kruppel family member GLI3 | 0.696 | |
Hmx3 | H6 homeobox 3 | 0.695 | |
Ptch1 | patched homolog 1 | 0.685 | |
Stat5b | signal transducer and activator of transcription 5B | 0.667 | |
Ror2 | receptor tyrosine kinase-like orphan receptor 2 | 0.663 | |
Dicer1 | Dicer1, Dcr-1 homolog (Drosophila) | 0.653 | |
Tgfb1 | transforming growth factor, beta 1 | 0.622 | |
Alx4 | aristaless-like homeobox 4 | 0.621 | |
Jag1 | jagged 1 | 0.592 | |
Smo | smoothened homolog (Drosophila) | 0.589 | |
Egfr | epidermal growth factor receptor | 0.585 | |
Pax9 | paired box gene 9 | 0.581 | |
Skil | SKI-like | 0.576 | |
Wnt3a | wingless-related MMTV integration site 3A | 0.556 | |
Tgfb2 | transforming growth factor, beta 2 | 0.551 | |
Slit3 | slit homolog 3 (Drosophila) | 0.551 | |
Runx2 | runt related transcription factor 2 | 0.545 | |
Eya1 | eyes absent 1 homolog (Drosophila) | 0.529 | |
Hoxa2 | homeobox A2 | 0.505 | |
Vangl2 | vang-like 2 (van gogh, Drosophila) | 0.485 | |
Myod1 | myogenic differentiation 1 | 0.482 | |
Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha | 0.478 | |
Ror1 | receptor tyrosine kinase-like orphan receptor 1 | 0.477 | |
Gdnf | glial cell line derived neurotrophic factor | 0.471 | |
Ren1 | renin 1 structural | 0.468 | |
Ret | ret proto-oncogene | 0.468 | |
Smad6 | MAD homolog 6 (Drosophila) | 0.458 | |
Gli1 | GLI-Kruppel family member GLI1 | 0.456 | |
Lhx3 | LIM homeobox protein 3 | 0.456 | |
Gata4 | GATA binding protein 4 | 0.448 | |
Dkk1 | dickkopf homolog 1 (Xenopus laevis) | 0.446 | |
Gata6 | GATA binding protein 6 | 0.436 | |
Col4a3 | collagen, type IV, alpha 3 | 0.429 | |
Tcfap2a | transcription factor AP-2, alpha | 0.429 | |
Mmp14 | matrix metallopeptidase 14 (membrane-inserted) | 0.428 | |
Lif | leukemia inhibitory factor | 0.426 | |
Vdr | vitamin D receptor | 0.397 | |
Barx1 | BarH-like homeobox 1 | 0.391 | |
Hoxa13 | homeobox A13 | 0.388 | |
Bdnf | brain derived neurotrophic factor | 0.387 | |
Nf1 | neurofibromatosis 1 | 0.375 | |
Tgfa | transforming growth factor alpha | 0.366 | |
Nr5a1 | nuclear receptor subfamily 5, group A, member 1 | 0.362 | |
Ncoa3 | nuclear receptor coactivator 3 | 0.360 | |
Tbx2 | T-box 2 | 0.358 | |
Stat5a | signal transducer and activator of transcription 5A | 0.356 | |
Axin1 | axin 1 | 0.354 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
RARA | retinoic acid receptor, alpha | 0.986 | |
FGFR2 | fibroblast growth factor receptor 2 | 0.982 | |
EGFR | epidermal growth factor receptor | 0.890 | |
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.890 | |
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.861 | |
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.824 | |
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.816 | |
NCOA1 | nuclear receptor coactivator 1 | 0.764 | |
CREBBP | CREB binding protein | 0.710 | |
FGFR1 | fibroblast growth factor receptor 1 | 0.621 | |
NCOA2 | nuclear receptor coactivator 2 | 0.581 | |
FGF10 | fibroblast growth factor 10 | 0.549 | |
MEOX2 | mesenchyme homeobox 2 | 0.433 | |
FGF1 | fibroblast growth factor 1 (acidic) | 0.416 | |
EHF | ets homologous factor | 0.413 | |
NCOR2 | nuclear receptor corepressor 2 | 0.374 | |
S100A4 | S100 calcium binding protein A4 | 0.372 | |
IL4R | interleukin 4 receptor | 0.362 | |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.285 | |
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.269 | |
HR | hairless homolog (mouse) | 0.265 | |
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.259 | |
EFNA1 | ephrin-A1 | 0.235 | |
SOX10 | SRY (sex determining region Y)-box 10 | 0.216 | |
FSTL1 | follistatin-like 1 | 0.194 | |
JAK1 | Janus kinase 1 | 0.188 | |
TGFB3 | transforming growth factor, beta 3 | 0.177 | |
TGFB1 | transforming growth factor, beta 1 | 0.174 | |
EP300 | E1A binding protein p300 | 0.172 | |
RXRA | retinoid X receptor, alpha | 0.169 | |
S100A2 | S100 calcium binding protein A2 | 0.153 | |
TM4SF1 | transmembrane 4 L six family member 1 | 0.146 | |
POU3F2 | POU class 3 homeobox 2 | 0.134 | |
ESR1 | estrogen receptor 1 | 0.132 | |
CUEDC2 | CUE domain containing 2 | 0.130 | |
JDP2 | Jun dimerization protein 2 | 0.129 | |
ENG | endoglin | 0.122 | |
FGF7 | fibroblast growth factor 7 | 0.113 | |
BCL2L1 | BCL2-like 1 | 0.113 | |
GSK3B | glycogen synthase kinase 3 beta | 0.111 | |
DAXX | death-domain associated protein | 0.104 | |
PHLPP1 | PH domain and leucine rich repeat protein phosphatase 1 | 0.086 | |
NCK2 | NCK adaptor protein 2 | 0.083 | |
BAK1 | BCL2-antagonist/killer 1 | 0.079 | |
FHL2 | four and a half LIM domains 2 | 0.077 | |
CCND1 | cyclin D1 | 0.077 | |
CCND3 | cyclin D3 | 0.077 | |
CDK6 | cyclin-dependent kinase 6 | 0.075 | |
HIPK2 | homeodomain interacting protein kinase 2 | 0.075 | |
DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.071 | |
KAT2B | K(lysine) acetyltransferase 2B | 0.068 | |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.067 | |
FBXW11 | F-box and WD repeat domain containing 11 | 0.067 | |
ESR2 | estrogen receptor 2 (ER beta) | 0.066 | |
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.064 | |
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.062 | |
IGF1R | insulin-like growth factor 1 receptor | 0.060 | |
MSX1 | msh homeobox 1 | 0.057 | |
CAPRIN2 | caprin family member 2 | 0.055 | |
ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.054 | |
DCC | deleted in colorectal carcinoma | 0.054 | |
FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.054 | |
RUNX1 | runt-related transcription factor 1 | 0.053 | |
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.052 | |
CTTN | cortactin | 0.051 | |
DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.049 | |
BCL3 | B-cell CLL/lymphoma 3 | 0.046 | |
CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.046 | |
FZD1 | frizzled homolog 1 (Drosophila) | 0.045 | |
TRIP6 | thyroid hormone receptor interactor 6 | 0.045 | |
FRS2 | fibroblast growth factor receptor substrate 2 | 0.045 | |
BIK | BCL2-interacting killer (apoptosis-inducing) | 0.045 | |
FGFR3 | fibroblast growth factor receptor 3 | 0.045 | |
RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.044 | |
CAV2 | caveolin 2 | 0.044 | |
GHR | growth hormone receptor | 0.043 | |
TGFB2 | transforming growth factor, beta 2 | 0.042 | |
GRIP1 | glutamate receptor interacting protein 1 | 0.042 | |
SMAD2 | SMAD family member 2 | 0.042 | |
APC | adenomatous polyposis coli | 0.042 | |
DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.041 | |
STAT5A | signal transducer and activator of transcription 5A | 0.041 | |
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.040 | |
TGFBR1 | transforming growth factor, beta receptor 1 | 0.039 | |
OGN | osteoglycin | 0.039 | |
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.039 | |
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.038 | |
PTPRF | protein tyrosine phosphatase, receptor type, F | 0.037 | |
STK36 | serine/threonine kinase 36 | 0.036 | |
FGF3 | fibroblast growth factor 3 | 0.036 | |
WNT3A | wingless-type MMTV integration site family, member 3A | 0.036 | |
SP1 | Sp1 transcription factor | 0.035 | |
TRRAP | transformation/transcription domain-associated protein | 0.035 | |
SNAPIN | SNAP-associated protein | 0.034 | |
SLC25A6 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | 0.032 | |
THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.032 | |
BMP2 | bone morphogenetic protein 2 | 0.031 | |
IMPDH2 | IMP (inosine 5'-monophosphate) dehydrogenase 2 | 0.031 | |
SUFU | suppressor of fused homolog (Drosophila) | 0.031 | |
PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.030 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Rara | retinoic acid receptor, alpha | 0.314 | |
Bmp7 | bone morphogenetic protein 7 | 0.047 | |
Capn5 | calpain 5 | 0.045 | |
Ddr1 | discoidin domain receptor tyrosine kinase 1 | 0.042 | |
Vom2r44 | vomeronasal 2 receptor 44 | 0.036 | |
Prrx1 | paired related homeobox 1 | 0.028 | |
Smad3 | SMAD family member 3 | 0.028 | |
Met | met proto-oncogene | 0.027 | |
Itpkb | inositol 1,4,5-trisphosphate 3-kinase B | 0.027 | |
Ctf1 | cardiotrophin 1 | 0.025 | |
Eif2ak2 | eukaryotic translation initiation factor 2-alpha kinase 2 | 0.022 | |
Rarg | retinoic acid receptor, gamma | 0.022 | |
Fat2 | FAT tumor suppressor homolog 2 (Drosophila) | 0.022 | |
Gata3 | GATA binding protein 3 | 0.021 | |
Utrn | utrophin | 0.021 | |
Socs3 | suppressor of cytokine signaling 3 | 0.020 | |
Fgf14 | fibroblast growth factor 14 | 0.019 | |
Ptpn14 | protein tyrosine phosphatase, non-receptor type 14 | 0.018 | |
Rab3il1 | RAB3A interacting protein (rabin3)-like 1 | 0.018 | |
Ucp2 | uncoupling protein 2 (mitochondrial, proton carrier) | 0.018 | |
Hoxc4 | homeo box C4 | 0.017 | |
Bak1 | BCL2-antagonist/killer 1 | 0.016 | |
Itpr2 | inositol 1,4,5-triphosphate receptor, type 2 | 0.016 | |
Pgr | progesterone receptor | 0.016 | |
LOC100365106 | rCG32755-like | 0.015 | |
Col4a5 | collagen, type IV, alpha 5 | 0.015 | |
Sox4 | SRY (sex determining region Y)-box 4 | 0.014 | |
Golim4 | golgi integral membrane protein 4 | 0.014 | |
Fbln5 | fibulin 5 | 0.014 | |
Stxbp2 | syntaxin binding protein 2 | 0.014 | |
Ralgds | ral guanine nucleotide dissociation stimulator | 0.014 | |
Pdzk1ip1 | PDZK1 interacting protein 1 | 0.014 | |
Dchs1 | dachsous 1 (Drosophila) | 0.013 | |
Slco2a1 | solute carrier organic anion transporter family, member 2a1 | 0.013 | |
Mmp23 | matrix metallopeptidase 23 | 0.013 | |
Sod3 | superoxide dismutase 3, extracellular | 0.013 | |
Mmp14 | matrix metallopeptidase 14 (membrane-inserted) | 0.012 | |
Ccdc3 | coiled-coil domain containing 3 | 0.012 | |
Bcl2 | B-cell CLL/lymphoma 2 | 0.012 | |
Kitlg | KIT ligand | 0.012 | |
Myo1d | myosin ID | 0.012 | |
Shox2 | short stature homeobox 2 | 0.011 | |
Erbb3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.011 | |
Tmem79 | transmembrane protein 79 | 0.011 | |
Cad | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.010 | |
Ceacam1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.010 | |
Capn1 | calpain 1 | 0.010 | |
Nr2f6 | nuclear receptor subfamily 2, group F, member 6 | 0.010 | |
Plcg2 | phospholipase C, gamma 2 | 0.010 |